mood disorders

Reducing Racial/Ethnic Disparities in Childhood Obesity: The Role of Early Life Risk Factors.

Reducing Racial/Ethnic Disparities in Childhood Obesity: The Role of Early Life Risk Factors.

JAMA Pediatr. 2013 Jun 3; 1-7
Taveras EM, Gillman MW, Kleinman KP, Rich-Edwards JW, Rifas-Shiman SL

IMPORTANCE Many early life risk factors for childhood obesity are… Continue reading →

Psychological Responses and Adherence to Exercise in Heart Failure.

Psychological Responses and Adherence to Exercise in Heart Failure.

Rehabil Nurs. 2013 May 29;
Duncan K, Pozehl B, Hertzog M, Norman JF

PURPOSE: The purpose of this study was to describe psychological effects and exercise adherence during a multicomponent… Continue reading →

Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs.

Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs.

PLoS One. 2013; 8(5): e61202
Tamir S, Zuris JA, Agranat L, Lipper CH, Conlan AR, Michaeli D, Harir Y, Paddock ML, Mittler R, Cabantchik ZI,… Continue reading →

Life-Review Interventions as Psychotherapeutic Techniques in Psychotraumatology.

Life-review interventions as psychotherapeutic techniques in psychotraumatology.

Eur J Psychotraumatol. 2013; 4:
Maercker A, Bachem R

Life-review interventions (LRI) are psychotherapeutic techniques originally derived from gerontology, which can be distinguished from other biographical and reminiscing techniques. They have been… Continue reading →

Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial Dysfunction.

Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial Dysfunction.

PLoS One. 2013; 8(5): e63302
Chakravarty S, Reddy BR, Sudhakar SR, Saxena S, Das T, Meghah V, Brahmendra Swamy… Continue reading →

Prospective, Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With Mood Disorders.

Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders.

Patient Prefer Adherence. 2013; 7: 411-417
Sajatovic M, Thompson TR, Nanry K, Edwards S, Manjunath R

Lamotrigine is an anticonvulsant drug indicated… Continue reading →

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity Versus Functional Activities.

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Medchemcomm. 2013 May 1; 4(5): 847-851
Yuan Y, Arnatt CK, El-Hage N, Dever SM, Jacob JC, Selley DE, Hauser KF,… Continue reading →

Huntingtin Mediates Anxiety/depression-Related Behaviors and Hippocampal Neurogenesis.

Huntingtin mediates anxiety/depression-related behaviors and hippocampal neurogenesis.

J Neurosci. 2013 May 15; 33(20): 8608-20
Ben M’barek K, Pla P, Orvoen S, Benstaali C, Godin JD, Gardier AM, Saudou F, David DJ, Humbert S

Huntington disease (HD) is associated with… Continue reading →

Pearls and Pitfalls in Experimental Models of Spreading Depression.

Pearls and pitfalls in experimental models of spreading depression.

Cephalalgia. 2013 Jun; 33(8): 604-13
Ayata C

Spreading depression (SD) is the electrophysiological substrate of migraine aura and a potential trigger for headache. Since its discovery by Leão in 1944,… Continue reading →

Atkins Diet Phase 1 Losing Weight?

Question by Loveyy: Atkins diet Phase 1 losing weight?
I’m a 17 year old female weighing 197, I really would like to lose 50 pounds in 5 months, I’m planing on doing the Atkins diet Phase 1 for the whole… Continue reading →